Name | Number of supported studies | Average coverage | |
---|---|---|---|
naive B cell | 5 studies | 17% ± 1% | |
B cell | 5 studies | 22% ± 5% | |
endothelial cell | 5 studies | 19% ± 4% | |
CD16-positive, CD56-dim natural killer cell, human | 4 studies | 19% ± 4% | |
astrocyte | 4 studies | 22% ± 5% | |
classical monocyte | 3 studies | 23% ± 2% | |
non-classical monocyte | 3 studies | 24% ± 5% | |
epithelial cell | 3 studies | 33% ± 11% | |
GABAergic neuron | 3 studies | 28% ± 3% | |
glutamatergic neuron | 3 studies | 31% ± 7% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 100% | 1157.15 | 180 / 180 | 100% | 7.61 | 430 / 430 |
lung | 100% | 936.03 | 578 / 578 | 100% | 7.58 | 1151 / 1155 |
brain | 99% | 719.79 | 2628 / 2642 | 100% | 15.09 | 705 / 705 |
prostate | 100% | 822.26 | 245 / 245 | 99% | 9.10 | 498 / 502 |
stomach | 100% | 785.78 | 359 / 359 | 99% | 6.83 | 283 / 286 |
esophagus | 100% | 767.46 | 1445 / 1445 | 99% | 5.81 | 181 / 183 |
thymus | 100% | 1281.49 | 653 / 653 | 99% | 9.32 | 598 / 605 |
breast | 100% | 1054.84 | 459 / 459 | 99% | 7.56 | 1105 / 1118 |
uterus | 100% | 1184.56 | 170 / 170 | 99% | 7.57 | 453 / 459 |
pancreas | 100% | 639.63 | 327 / 328 | 99% | 6.39 | 176 / 178 |
intestine | 100% | 1086.73 | 966 / 966 | 98% | 7.56 | 517 / 527 |
bladder | 100% | 793.67 | 21 / 21 | 98% | 6.73 | 494 / 504 |
adrenal gland | 100% | 776.03 | 258 / 258 | 97% | 7.54 | 223 / 230 |
kidney | 100% | 697.78 | 89 / 89 | 96% | 9.58 | 865 / 901 |
skin | 100% | 652.79 | 1808 / 1809 | 95% | 8.26 | 448 / 472 |
liver | 100% | 462.57 | 226 / 226 | 78% | 3.14 | 317 / 406 |
adipose | 100% | 1056.13 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 955.30 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 8.96 | 29 / 29 |
spleen | 100% | 1640.08 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 2.01 | 1 / 1 |
heart | 99% | 539.25 | 852 / 861 | 0% | 0 | 0 / 0 |
muscle | 99% | 445.08 | 794 / 803 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 7.70 | 44 / 45 |
peripheral blood | 88% | 684.09 | 816 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 84% | 4.81 | 67 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_2000779 | Biological process | regulation of double-strand break repair |
GO_0006338 | Biological process | chromatin remodeling |
GO_0042981 | Biological process | regulation of apoptotic process |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0006355 | Biological process | regulation of DNA-templated transcription |
GO_1905168 | Biological process | positive regulation of double-strand break repair via homologous recombination |
GO_0051726 | Biological process | regulation of cell cycle |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0000812 | Cellular component | Swr1 complex |
GO_0000786 | Cellular component | nucleosome |
GO_0005654 | Cellular component | nucleoplasm |
GO_0035267 | Cellular component | NuA4 histone acetyltransferase complex |
GO_0032777 | Cellular component | piccolo histone acetyltransferase complex |
GO_0005634 | Cellular component | nucleus |
GO_0035064 | Molecular function | methylated histone binding |
GO_0043997 | Molecular function | histone H4K12 acetyltransferase activity |
GO_0046972 | Molecular function | histone H4K16 acetyltransferase activity |
GO_0043996 | Molecular function | histone H4K8 acetyltransferase activity |
GO_0010485 | Molecular function | histone H4 acetyltransferase activity |
GO_0043995 | Molecular function | histone H4K5 acetyltransferase activity |
GO_0046872 | Molecular function | metal ion binding |
GO_0043998 | Molecular function | histone H2A acetyltransferase activity |
Gene name | ING3 |
Protein name | Inhibitor of growth protein 3 (p47ING3) ING3 protein Inhibitor of growth protein Inhibitor of growth family member 3 |
Synonyms | HSPC301 |
Description | FUNCTION: Component of the NuA4 histone acetyltransferase (HAT) complex which is involved in transcriptional activation of select genes principally by acetylation of nucleosomal histones H4 and H2A. This modification may both alter nucleosome - DNA interactions and promote interaction of the modified histones with other proteins which positively regulate transcription. This complex may be required for the activation of transcriptional programs associated with oncogene and proto-oncogene mediated growth induction, tumor suppressor mediated growth arrest and replicative senescence, apoptosis, and DNA repair. NuA4 may also play a direct role in DNA repair when directly recruited to sites of DNA damage. Component of a SWR1-like complex that specifically mediates the removal of histone H2A.Z/H2AZ1 from the nucleosome. . FUNCTION: Component of an histone acetyltransferase complex. . |
Accessions | A0A0C4DG38 ENST00000315870.10 [Q9NXR8-1] ENST00000431467.1 Q9NXR8 E7ET07 B7ZKQ7 ENST00000445699.5 ENST00000427726.5 [Q9NXR8-3] ENST00000339121.9 [Q9NXR8-2] |